| RS121908458 |
MYOT
|
Health Risk |
Pathogenic/Likely pathogenic |
Myofibrillar myopathy 3, Myofibrillar myopathy |
| RS121908461 |
MYOT
|
Health Risk |
Pathogenic/Likely pathogenic |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS121908462 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, Abnormality of the nervous system |
| RS121908463 |
ADGRG1
|
Health Risk |
Likely pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS121908464 |
ADGRG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS121908465 |
ADGRG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS121908466 |
ADGRG1
|
Health Risk |
Pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS121908467 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908468 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908469 |
ADAMTS13
|
Health Risk |
Pathogenic/Likely pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908470 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Thrombotic thrombocytopenic purpura |
| RS121908471 |
ADAMTS13
|
Health Risk |
Likely pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908472 |
ADAMTS13
|
Health Risk |
Pathogenic/Likely pathogenic |
Upshaw-Schulman syndrome, Thrombotic thrombocytopenic purpura |
| RS121908474 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908475 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908476 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908477 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908478 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS121908479 |
SLC7A9
|
Health Risk |
Pathogenic |
Cystinuria, Cystinuria |
| RS121908480 |
SLC7A9
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystinuria, SLC7A9-related disorder |
| RS121908482 |
SLC7A9
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystinuria, Cystinuria |
| RS121908483 |
SLC7A9
|
Health Risk |
Likely pathogenic |
Cystinuria, Cystinuria |
| RS121908484 |
SLC7A9
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystinuria, SLC7A9-related disorder |
| RS121908485 |
SLC7A9
|
Health Risk |
Pathogenic |
Cystinuria, Cystinuria |
| RS121908487 |
SLC7A9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Cystinuria |
| RS121908489 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Inborn genetic diseases |
| RS121908490 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, SGCE-related disorder |
| RS121908491 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS121908492 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS121908493 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS121908494 |
SLC6A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperekplexia 3, Hyperekplexia 3 |
| RS121908495 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS121908496 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS121908497 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS121908499 |
KISS1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Central precocious puberty 1, Hypogonadotropic hypogonadism 8 with or without anosmia |
| RS121908500 |
DLC1
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121908501 |
STAT5B
|
Health Risk |
Pathogenic |
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive |
| RS121908502 |
STAT5B
|
Health Risk |
Pathogenic |
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive |
| RS121908508 |
SCO2
|
Health Risk |
Pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS121908509 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS121908510 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS121908511 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Spastic paraparesis |
| RS121908512 |
SPAST
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 4, Tics |
| RS121908513 |
SPAST
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS121908514 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS121908515 |
SPAST
|
Health Risk |
Benign/Likely benign; other; risk factor |
Hereditary spastic paraplegia 4, Cerebral palsy |
| RS121908516 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS121908517 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS121908518 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS121908519 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS121908520 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS121908521 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS121908522 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS121908523 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS121908524 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS121908525 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS121908526 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS121908527 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS121908528 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS121908529 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS121908530 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS121908531 |
DNM1L
|
Health Risk |
Pathogenic |
Encephalopathy, lethal |
| RS121908532 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type II, Inborn genetic diseases |
| RS121908533 |
SLC25A15
|
Health Risk |
Pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS121908534 |
SLC25A15
|
Health Risk |
Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS121908535 |
SLC25A15
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Congenital portosystemic shunt |
| RS121908536 |
SLC25A15
|
Health Risk |
Pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS121908537 |
SUCLA2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS121908538 |
SUCLA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS121908541 |
EIF2B5
|
Health Risk |
Pathogenic |
Leukoencephalopathy with vanishing white matter 5, Leukoencephalopathy with vanishing white matter 5 |
| RS121908542 |
CLDN16
|
Health Risk |
Pathogenic |
HYPERCALCIURIA, CHILDHOOD |
| RS121908543 |
CLDN16
|
Health Risk |
Pathogenic |
Primary hypomagnesemia, Primary hypomagnesemia |
| RS121908544 |
SCN4A
|
Health Risk |
Pathogenic |
Paramyotonia congenita of Von Eulenburg, Hyperkalemic periodic paralysis |
| RS121908545 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Paramyotonia congenita of Von Eulenburg, Hyperkalemic periodic paralysis |
| RS121908546 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Paramyotonia congenita/myotonia congenita, Myotonia fluctuans |
| RS121908547 |
SCN4A
|
Health Risk |
Pathogenic |
Paramyotonia congenita of Von Eulenburg, Hyperkalemic periodic paralysis |
| RS121908548 |
SCN4A
|
Health Risk |
Pathogenic |
Potassium-aggravated myotonia, Paramyotonia congenita of Von Eulenburg |
| RS121908549 |
SCN4A
|
Health Risk |
Pathogenic |
Myotonia congenita, atypical |
| RS121908550 |
SCN4A
|
Health Risk |
Pathogenic |
Paramyotonia congenita of Von Eulenburg, SCN4A-related non-dystrophic myotonia |
| RS121908551 |
SCN4A
|
Health Risk |
Likely pathogenic |
Paramyotonia congenita of Von Eulenburg, SCN4A-related disorder |
| RS121908552 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Potassium-aggravated myotonia, Hyperkalemic periodic paralysis |
| RS121908554 |
SCN4A
|
Health Risk |
Likely pathogenic |
Paramyotonia congenita of Von Eulenburg, Paramyotonia congenita of Von Eulenburg |
| RS121908555 |
SCN4A
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 2 |
| RS121908556 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Normokalemic periodic paralysis, potassium-sensitive |
| RS121908557 |
SCN4A
|
Health Risk |
Pathogenic |
Normokalemic periodic paralysis, potassium-sensitive |
| RS121908559 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Paramyotonia congenita of Von Eulenburg, Hyperkalemic periodic paralysis |
| RS121908560 |
SCN4A
|
Health Risk |
Pathogenic |
Paramyotonia congenita/hyperkalemic periodic paralysis, Paramyotonia congenita of Von Eulenburg |
| RS121908561 |
SCN4A
|
Health Risk |
Pathogenic |
Paramyotonia congenita of Von Eulenburg, Paramyotonia congenita of Von Eulenburg |
| RS121908562 |
POLH
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS121908563 |
POLH
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS121908564 |
POLH
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS121908566 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 11, Long QT syndrome |
| RS121908567 |
AXIN2
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121908568 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS121908569 |
EIF2AK3
|
Health Risk |
Pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS121908570 |
EIF2AK3
|
Health Risk |
Pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS121908571 |
BCS1L
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 1, Mitochondrial complex III deficiency nuclear type 1 |
| RS121908572 |
BCS1L
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 1, GRACILE syndrome |
| RS121908573 |
BCS1L
|
Health Risk |
Likely pathogenic |
Mitochondrial complex III deficiency nuclear type 1, Pili torti-deafness syndrome |
| RS121908574 |
BCS1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 1, Pili torti-deafness syndrome |